Rest Ez Inc. (RTEZ)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Rest Ez Inc. (RTEZ) trades at $70.00 with AI Score 38/100 (Grade D). Rest EZ, Inc. produces and distributes sleeping aid soft gel capsules under the brand Rest EZ in the United States. Market cap: $1.93B, Sector: Healthcare.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for RTEZ: RTEZ does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RTEZ against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
RTEZ: 1/1 perspectives are bearish.
How is this calculated? →Rest Ez Inc. (RTEZ) Healthcare & Pipeline Overview
Rest EZ, Inc. is a US-based pharmaceutical company focused on producing and distributing its Rest EZ sleep aid supplement. Operating in the competitive sleep aid market, the company utilizes wholesalers, retailers, and direct online sales to reach consumers seeking over-the-counter sleep solutions.
What Is the Investment Thesis for RTEZ?
Rest EZ, Inc. presents a high-risk, high-reward investment opportunity given its small size and OTC status. The company's focus on a single product, Rest EZ sleep aid capsules, creates both opportunity and vulnerability. Key value drivers include successful marketing and distribution strategies that can expand market share within the growing sleep aid market. A P/E ratio of 58411.82 indicates that the stock may be overvalued. The company's beta of 1.72 suggests higher volatility compared to the market. Growth catalysts include potential partnerships with larger retailers and expansion into new geographic markets within the US. However, the company faces risks related to competition, regulatory changes, and reliance on a single product.
Based on FMP financials and quantitative analysis
RTEZ Key Highlights
- Rest EZ, Inc. operates with a market capitalization of $1.93B, reflecting its position as a smaller player in the broader healthcare landscape.
- The company's P/E ratio stands at 58411.82, indicating a potentially high valuation relative to its earnings.
- Rest EZ, Inc. has a beta of 1.72, suggesting the stock is more volatile than the overall market.
- The company's focus on a single product, Rest EZ sleep aid capsules, represents both a specialization and a concentration risk.
- Rest EZ, Inc. distributes its product through wholesalers, retailers, and its online platform, www.RestEz.net, indicating a multi-channel distribution strategy.
Who Are RTEZ's Competitors?
RTEZ is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| EBOSY EBOS Group Limited | $24.13 | -7.19% | $1.24B | 42 |
| EKTAF Elekta AB (publ) | $5.25 | +4.17% | $1.93B | 47 |
| EKTAY Elekta AB (publ) | $5.33 | +0.85% | $2.04B | 47 |
| HTSUY Hisamitsu Pharmaceutical Co., Inc. | $2.94 | +0.00% | $839.03M | — |
| ONTTF Oxford Nanopore Technologies plc | $1.70 | +4.29% | $1.66B | 59 |
| ATAI Atai Beckley NV is a clinical-stage biopharmaceutical company focused on developing treatments for mental health disorders. The company | $4.88 | -5.97% | $1.80B | 68 |
| MEDS TRxADE HEALTH, Inc. | $7.59 | +4.55% | $13.28M | 63 |
| ONC BeOne Medicines Ltd. | $309.46 | +3.97% | $33.07B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RTEZ's Key Strengths?
- Focus on a specific product (sleep aid capsules).
- Multi-channel distribution strategy (wholesalers, retailers, online).
- Established online presence through www.RestEz.net.
- Relatively young company, allowing for agility and adaptability.
What Are RTEZ's Weaknesses?
- Reliance on a single product.
- Limited brand recognition compared to larger competitors.
- Small market capitalization.
- High P/E ratio, indicating potential overvaluation.
What Could Drive RTEZ Stock Higher?
- Potential partnerships with major retail chains to expand distribution.
- Launch of new product formulations or delivery methods for sleep aid supplements.
- Increased marketing efforts to build brand awareness and drive sales.
- Expansion into new geographic markets within the United States.
- Positive clinical trial results supporting the efficacy of Rest EZ.
What Are the Key Risks for RTEZ?
- Increased competition from established pharmaceutical companies and generic brands.
- Changes in regulations governing dietary supplements could impact product formulation or marketing.
- Negative publicity or product recalls could damage the company's reputation.
- Reliance on a single product makes the company vulnerable to market shifts or product obsolescence.
- Economic downturn could affect consumer spending on non-essential products.
What Are the Growth Opportunities for RTEZ?
- Expansion of Online Sales Channels: Rest EZ can leverage the growing e-commerce trend by enhancing its online platform, www.RestEz.net, and expanding its presence on major online marketplaces like Amazon and Walmart.com. The global e-commerce market is projected to reach $6.3 trillion in 2026, offering a significant opportunity for Rest EZ to increase its direct-to-consumer sales and brand visibility. Timeline: Within the next 1-2 years, Rest EZ can invest in improving its website user experience, search engine optimization (SEO), and digital marketing campaigns to drive online sales growth.
- Strategic Partnerships with Retail Chains: Rest EZ can pursue partnerships with major retail chains, such as CVS, Walgreens, and Walmart, to increase its product distribution and reach a wider customer base. These retailers have established distribution networks and customer loyalty programs that can benefit Rest EZ. The retail pharmacy market in the US is estimated at $300 billion annually, providing a substantial opportunity for Rest EZ to expand its retail presence. Timeline: Within the next 2-3 years, Rest EZ can focus on building relationships with retail buyers and demonstrating the value proposition of its Rest EZ sleep aid capsules.
- Product Line Extension: Rest EZ can expand its product line by introducing new formulations, dosages, or delivery methods for its sleep aid supplement. This can include developing a fast-dissolving tablet, a liquid formulation, or a higher-strength capsule to cater to different consumer preferences and needs. The dietary supplement market is characterized by innovation and product differentiation, with new products constantly being introduced to meet evolving consumer demands. Timeline: Within the next 3-4 years, Rest EZ can invest in research and development to create new product variations and conduct clinical trials to support their efficacy and safety.
- Geographic Expansion within the United States: Rest EZ can expand its distribution network to new geographic regions within the United States, targeting areas with high demand for sleep aid products. This can involve partnering with regional distributors, attending trade shows, and conducting targeted marketing campaigns. The US sleep aid market is fragmented, with regional variations in consumer preferences and purchasing patterns. Timeline: Within the next 2-3 years, Rest EZ can conduct market research to identify promising geographic regions and develop tailored distribution and marketing strategies.
- Targeted Marketing Campaigns: Rest EZ can implement targeted marketing campaigns to reach specific customer segments, such as seniors, shift workers, and individuals with anxiety or stress-related sleep problems. This can involve using social media, online advertising, and content marketing to educate consumers about the benefits of Rest EZ and address their specific needs. The sleep aid market is increasingly segmented, with consumers seeking personalized solutions for their sleep problems. Timeline: Ongoing, Rest EZ can continuously refine its marketing strategies based on customer feedback and market trends.
What Opportunities Does RTEZ Have?
- Expansion into new geographic markets within the US.
- Development of new product formulations or delivery methods.
- Partnerships with major retail chains.
- Increased marketing efforts to build brand awareness.
What Threats Does RTEZ Face?
- Competition from established pharmaceutical companies.
- Changes in regulations governing dietary supplements.
- Negative publicity or product recalls.
- Economic downturn affecting consumer spending on non-essential products.
What Are RTEZ's Competitive Advantages?
- Established online sales channel through www.RestEz.net.
- Existing relationships with wholesalers and retailers.
- Brand recognition, if any, for the 'Rest EZ' product name.
What Does RTEZ Do?
Rest EZ, Inc., established in 2016 and headquartered in Riverton, Utah, operates within the healthcare sector, specifically focusing on the production and distribution of sleep aid supplements. The company's primary product, Rest EZ, is a soft gel capsule designed to aid sleep. Rest EZ utilizes a multi-channel distribution strategy, making its product available through wholesalers, retailers, and directly to consumers via its online platform, www.RestEz.net. This approach allows the company to reach a broad customer base across the United States. As a relatively young company, Rest EZ is focused on establishing its brand presence and market share within the competitive over-the-counter (OTC) sleep aid market. The company's success depends on its ability to effectively market its product, maintain quality control, and navigate the regulatory landscape governing the sale of dietary supplements.
What Products and Services Does RTEZ Offer?
- Rest EZ produces sleep aid soft gel capsules.
- The company distributes its products in the United States.
- Rest EZ offers a sleep aid supplement called Rest EZ.
- They sell through wholesalers.
- They sell through retailers.
- Rest EZ sells its product online through www.RestEz.net.
How Does RTEZ Make Money?
- Rest EZ manufactures and packages its Rest EZ sleep aid capsules.
- The company generates revenue through the sale of its product to wholesalers and retailers.
- Rest EZ also sells directly to consumers through its online platform, www.RestEz.net.
What Industry Does RTEZ Operate In?
Rest EZ, Inc. operates within the competitive medical-pharmaceuticals sector, specifically targeting the sleep aid market. The industry is characterized by increasing demand for over-the-counter sleep solutions, driven by factors such as stress, aging populations, and changing lifestyles. Key competitors include companies like EBOSY (EBOS Group), EKTAF (Eckert & Ziegler Strahlen), EKTAY (Eckert & Ziegler Strahlen), HTSUY (Haseko Corp), and ONTTF (Otonomy Inc). These companies offer a range of sleep-related products and services. Rest EZ's success depends on its ability to differentiate its product, effectively market to consumers, and navigate the regulatory landscape governing the sale of dietary supplements.
Who Are RTEZ's Key Customers?
- Individuals seeking over-the-counter sleep aids.
- Wholesalers who distribute health and wellness products.
- Retailers, including pharmacies and supermarkets, that sell sleep aids.
ROE 11%Key Financial Metrics
Return on equity for Rest Ez Inc. stands at 11.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 11.0%, showing how much profit it generates from its asset base. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
Rest Ez Inc. (RTEZ) Valuation Context
Valued at $1.93B, RTEZ is classified as a small-cap stock. Relative to its peer group, RTEZ's quantitative score of 38/100 is below the peer average of 49/100.
Company Profile
Rest Ez Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Riverton, US. The company is led by CEO Dylan Carson. RTEZ has traded publicly since 2025.
RTEZ Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Focus on a specific product (sleep aid capsules).
- Multi-channel distribution strategy (wholesalers, retailers, online).
- Established online presence through www.RestEz.net.
- Relatively young company, allowing for agility and adaptability.
Bear Case
- Reliance on a single product.
- Limited brand recognition compared to larger competitors.
- Small market capitalization.
- High P/E ratio, indicating potential overvaluation.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
RTEZ Latest News
No recent news available for RTEZ.
RTEZ Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RTEZ.
Price Targets
Wall Street price target analysis for RTEZ.
RTEZ MoonshotScore
What does this score mean?
The MoonshotScore rates RTEZ's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Dylan Carson
CEO
Dylan Carson is the CEO of Rest Ez Inc. His background includes experience in the pharmaceutical and wellness industries. Prior to joining Rest Ez, Carson held various leadership positions in sales and marketing at companies focused on consumer health products. He has a track record of driving revenue growth and building brand awareness. Carson holds a degree in Business Administration from a leading university.
Track Record: Since becoming CEO of Rest Ez Inc., Dylan Carson has focused on expanding the company's distribution network and increasing its online presence. He has overseen the launch of several marketing campaigns to promote the Rest EZ sleep aid capsules. Under his leadership, the company has maintained its focus on quality control and regulatory compliance.
RTEZ OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Rest Ez Inc. may not meet the minimum financial or disclosure requirements of the higher tiers (OTCQX and OTCQB). Companies in this tier may have limited financial reporting, making it more difficult for investors to assess their financial health and performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies are not subject to the same stringent listing standards and regulatory oversight. This can result in greater information asymmetry and increased risk for investors.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Low trading volume and liquidity.
- Potential for price manipulation.
- Higher risk of fraud or mismanagement.
- Lack of regulatory oversight.
- Verify the company's registration and legal status.
- Obtain and review available financial statements.
- Assess the company's management team and their experience.
- Research the company's product and market position.
- Evaluate the company's regulatory compliance.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor.
- Established online presence through www.RestEz.net.
- Distribution agreements with wholesalers and retailers.
- Focus on a specific product (sleep aid capsules).
- CEO with experience in the pharmaceutical industry.
- Incorporation date of 2016 suggests some operating history.
Rest Ez Inc. Healthcare Stock: Key Questions Answered
What does Rest Ez Inc. do?
Rest Ez Inc. is a healthcare company that specializes in the production and distribution of sleep aid supplements. Its primary product, Rest EZ, is a soft gel capsule designed to help individuals fall asleep faster and improve sleep quality. The company distributes its products through wholesalers, retailers, and directly to consumers via its online platform, www.RestEz.net. Rest EZ aims to provide accessible and effective over-the-counter sleep solutions to address the growing demand for sleep aids in the United States.
What do analysts say about RTEZ stock?
Analyst coverage of Rest Ez Inc. (RTEZ) is currently limited, likely due to its OTC listing and smaller market capitalization. Key valuation metrics, such as the P/E ratio of 58411.82, suggest that the stock may be overvalued relative to its earnings. Growth considerations include the company's ability to expand its distribution network, introduce new products, and effectively market its Rest EZ sleep aid capsules. Investors should conduct their own thorough research and consider the risks associated with investing in OTC stocks before making any investment decisions.
What are the main risks for RTEZ?
Rest Ez Inc. faces several key risks, including its reliance on a single product, Rest EZ sleep aid capsules, which makes it vulnerable to market shifts and competition. The company also operates in a highly regulated industry, and changes in regulations governing dietary supplements could impact its product formulation or marketing. Furthermore, as an OTC-listed company, Rest Ez Inc. is subject to greater liquidity risk and potential for price volatility. Competition from larger pharmaceutical companies with greater resources and established brands also poses a significant threat.
What are the key factors to evaluate for RTEZ?
Rest Ez Inc. (RTEZ) holds an AI score of 38/100 (low). Not financial advice.
How frequently does RTEZ data refresh on this page?
RTEZ prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven RTEZ's recent stock price performance?
Rest Ez Inc. (RTEZ) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on a specific product (sleep aid capsules). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RTEZ overvalued or undervalued right now?
Valuing Rest Ez Inc. (RTEZ) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying RTEZ?
Before investing in Rest Ez Inc. (RTEZ), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on OTC-listed companies.
- Financial data may not be readily accessible or audited.